RxDoctor Payments Data

Susan Marshall, APRN

Psychiatric/Mental Health · Carbondale, KSNPI 1366005357

Payments from drug & device makers

$2,031in general payments, 2019–2025

Across 135 payments — averaging $15.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$368
  • Supernus Pharmaceuticals, Inc.$244
  • Axsome Therapeutics, Inc.$201
  • Takeda Pharmaceuticals U.S.A., Inc.$188
  • Corium, LLC$165
  • Otsuka America Pharmaceutical, Inc.$147
  • plus $719 from 11 others

What the payments were for

  • Food & beverage$2,031100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,031 in reported general payments places this provider in the 75th percentile of 404 psychiatric/mental health providers in Kansas.

See all psychiatric/mental health providers in Kansas

Medicare billing

Part B allowed, 2024
$17,934
Medicare patients
65
Services billed
176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine11$113,183
VraylarCariprazine Hcl14$24,784
Aripiprazole57$14,072
Lisdexamfetamine Dimesylate21$4,104
Guanfacine Hcl ErGuanfacine Hcl27$2,884
Lurasidone Hcl12$2,842
Fluvoxamine Maleate39$1,854
Atomoxetine Hcl25$1,451
Paliperidone ErPaliperidone11$1,419
Quetiapine Fumarate23$1,308
Divalproex Sodium ErDivalproex Sodium18$1,303
Oxcarbazepine35$1,227
Duloxetine Hcl33$991
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine11$910
Olanzapine30$903

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$62$113,18311 claims
AbbVieVraylar$368$24,78414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 404 psychiatric/mental health providers in Kansas.

Other psychiatric/mental health in Carbondale

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →